Aktive Positionen von Aurelien Valet
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Graftys SA
 Graftys SA Medical SpecialtiesHealth Technology Graftys SA designs, manufactures and markets calcium phosphate-based synthetic bone substitutes to the global orthopedic and dental surgery markets. Its research and development projects include injectable and resorbable synthetic bone substitutes, biological repair of cartilage and of the spine, as well as bone substitutes combined with pharmaceutical agents. The company was founded by Jean Marc Ferrier, Alain Valet, Jean-Michel Bouler and Aurélien Valet in September 2005 and is headquartered in Aix-en-Provence, France. | Direktor/Vorstandsmitglied | 01.09.2005 | - |
| Gründer | 01.09.2005 | - |
Karriereverlauf von Aurelien Valet
Ehemalige bekannte Positionen von Aurelien Valet
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Biologics 4 Life SAS
 Biologics 4 Life SAS Pharmaceuticals: MajorHealth Technology Part of Graftys SA, Biologics 4 Life SAS develops injectable biomaterials to treat and prevent fractures caused by osteoporosis. The company is based in Jouques, France. The French company was founded in 2018 by Aurelien Valet, Alain Valet, Sébastien Genesta. Biologics 4 Life was acquired by Graftys SA on November 08, 2021. | Gründer | 01.01.2018 | 01.11.2021 |
| Präsident | 01.01.2018 | 01.11.2021 |
Statistik
International
| Frankreich | 3 |
Operativ
| Founder | 2 |
| Director/Board Member | 1 |
| President | 1 |
Sektoral
| Health Technology | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Graftys SA
Graftys SA Medical SpecialtiesHealth Technology Graftys SA designs, manufactures and markets calcium phosphate-based synthetic bone substitutes to the global orthopedic and dental surgery markets. Its research and development projects include injectable and resorbable synthetic bone substitutes, biological repair of cartilage and of the spine, as well as bone substitutes combined with pharmaceutical agents. The company was founded by Jean Marc Ferrier, Alain Valet, Jean-Michel Bouler and Aurélien Valet in September 2005 and is headquartered in Aix-en-Provence, France. | Health Technology |
Biologics 4 Life SAS
Biologics 4 Life SAS Pharmaceuticals: MajorHealth Technology Part of Graftys SA, Biologics 4 Life SAS develops injectable biomaterials to treat and prevent fractures caused by osteoporosis. The company is based in Jouques, France. The French company was founded in 2018 by Aurelien Valet, Alain Valet, Sébastien Genesta. Biologics 4 Life was acquired by Graftys SA on November 08, 2021. | Health Technology |
- Börse
- Insiders
- Aurelien Valet
- Erfahrung
